EP0832216A4 - Fibroblast growth factor 15 - Google Patents
Fibroblast growth factor 15Info
- Publication number
- EP0832216A4 EP0832216A4 EP95922978A EP95922978A EP0832216A4 EP 0832216 A4 EP0832216 A4 EP 0832216A4 EP 95922978 A EP95922978 A EP 95922978A EP 95922978 A EP95922978 A EP 95922978A EP 0832216 A4 EP0832216 A4 EP 0832216A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- growth factor
- fibroblast growth
- fibroblast
- factor
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101710153363 Fibroblast growth factor 15 Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/007156 WO1996039509A1 (en) | 1995-06-05 | 1995-06-05 | Fibroblast growth factor 15 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0832216A1 EP0832216A1 (en) | 1998-04-01 |
EP0832216A4 true EP0832216A4 (en) | 1999-06-16 |
Family
ID=22249254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95922978A Withdrawn EP0832216A4 (en) | 1995-06-05 | 1995-06-05 | Fibroblast growth factor 15 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0832216A4 (en) |
JP (1) | JPH11506919A (en) |
KR (1) | KR19990008319A (en) |
CA (1) | CA2217301A1 (en) |
WO (1) | WO1996039509A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876967A (en) * | 1995-05-12 | 1999-03-02 | The Johns Hopkins University School Of Medicine | Fibroblast growth factor homologous factor-2 and methods of use |
US5693775A (en) * | 1995-05-12 | 1997-12-02 | The Johns Hopkins University School Of Medicine | Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use |
US5728546A (en) | 1995-06-05 | 1998-03-17 | Human Genome Sciences, Inc. | Fibroblast growth factor 13 |
CA2249179A1 (en) * | 1996-03-21 | 1997-09-25 | The Johns Hopkins University School Of Medicine | Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
US6020189A (en) * | 1996-08-30 | 2000-02-01 | The Johns Hopkins University School Of Medicine | Fibroblast growth factor homologous factors (FHFs) and methods of use |
EP0942981A1 (en) * | 1996-11-27 | 1999-09-22 | Human Genome Sciences, Inc. | Fibroblast growth factor-13 |
WO2000060085A1 (en) * | 1999-04-02 | 2000-10-12 | Millennium Pharmaceuticals, Inc. | Fibroblast growth factor-20 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986007595A1 (en) * | 1985-06-20 | 1986-12-31 | The Salk Institute For Biological Studies | Fibroblast growth factor |
EP0246753A2 (en) * | 1986-04-22 | 1987-11-25 | The Salk Institute For Biological Studies | Fibroblast growth factor antagonists |
WO1995024414A1 (en) * | 1994-03-08 | 1995-09-14 | Human Genome Sciences, Inc. | Fibroblast growth factor-10 |
WO1996035708A1 (en) * | 1995-05-12 | 1996-11-14 | The Johns Hopkins University School Of Medicine | Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
US5773252A (en) * | 1995-06-05 | 1998-06-30 | Human Genome Sciences, Inc. | Fibroblast growth factor 15 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0608546A3 (en) * | 1992-12-22 | 1995-09-27 | Takeda Chemical Industries Ltd | Glia activating factor (gaf), antibodies against it and their uses. |
-
1995
- 1995-06-05 WO PCT/US1995/007156 patent/WO1996039509A1/en not_active Application Discontinuation
- 1995-06-05 KR KR1019970707845A patent/KR19990008319A/en not_active Application Discontinuation
- 1995-06-05 EP EP95922978A patent/EP0832216A4/en not_active Withdrawn
- 1995-06-05 JP JP9500364A patent/JPH11506919A/en active Pending
- 1995-06-05 CA CA002217301A patent/CA2217301A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986007595A1 (en) * | 1985-06-20 | 1986-12-31 | The Salk Institute For Biological Studies | Fibroblast growth factor |
EP0246753A2 (en) * | 1986-04-22 | 1987-11-25 | The Salk Institute For Biological Studies | Fibroblast growth factor antagonists |
WO1995024414A1 (en) * | 1994-03-08 | 1995-09-14 | Human Genome Sciences, Inc. | Fibroblast growth factor-10 |
WO1996035708A1 (en) * | 1995-05-12 | 1996-11-14 | The Johns Hopkins University School Of Medicine | Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
US5773252A (en) * | 1995-06-05 | 1998-06-30 | Human Genome Sciences, Inc. | Fibroblast growth factor 15 |
Non-Patent Citations (3)
Title |
---|
DATABASE EMBL - EMEST16 6 November 1994 (1994-11-06), AUFFRAY C. ET AL.: "H. sapiens partial cDNA sequence; clone c-zug03", XP002100270 * |
See also references of WO9639509A1 * |
SMALLWOOD P M ET AL: "FIBROBLAST GROWTH FACTOR (FGF) HOMOLOGOUS FACTORS: NEW MEMBERS OF THE FGF FAMILY IMPLICATED IN NERVOUS SYSTEM DEVELOPMENT", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 93, September 1996 (1996-09-01), pages 9850 - 9857, XP002058996 * |
Also Published As
Publication number | Publication date |
---|---|
KR19990008319A (en) | 1999-01-25 |
JPH11506919A (en) | 1999-06-22 |
AU711647B2 (en) | 1999-10-21 |
WO1996039509A1 (en) | 1996-12-12 |
AU2767495A (en) | 1996-12-24 |
EP0832216A1 (en) | 1998-04-01 |
CA2217301A1 (en) | 1996-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0871705A4 (en) | Human ccn-like growth factor | |
EP0725796A4 (en) | Growth differentiation factor-10 | |
IL114397A0 (en) | Growth/differentiation factor of the TGF-beta-family | |
GB2287970B (en) | "Decorative elements for subceilings" | |
EP0873348A4 (en) | Human vascular endothelial growth factor 3 | |
EP0904292A4 (en) | Growth differentiation factor-14 | |
GB2288196B (en) | "Decorative elements for subceilings" | |
GB9426400D0 (en) | Type 9/10 | |
GB9508596D0 (en) | "conveyors" | |
EP0833904A4 (en) | Fibroblast growth factor-14 | |
EP0832215A4 (en) | Fibroblast growth factor 11 | |
GB9518692D0 (en) | 'Spraymate' | |
IL112924A (en) | Easel | |
AU2697995A (en) | Fibroblast growth factor 13 | |
EP0832216A4 (en) | Fibroblast growth factor 15 | |
GB9508453D0 (en) | Type 120 | |
AU2002301359A1 (en) | Fibroblast Growth Factor 15 | |
AU2002300809A1 (en) | Fibroblast Growth Factor 11 | |
GB9424232D0 (en) | Growth factor expression | |
GB9225928D0 (en) | Growth factor | |
EP0891372A4 (en) | Growth factor htter36 | |
GB2267832B (en) | Prosthesis | |
EP0862626A4 (en) | Pilosulin 2 | |
DE69405544D1 (en) | 4'-0-sulfonylanthracyclinderivate | |
GB9611417D0 (en) | Prosthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19971105 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19990506 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20020822 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20060407 |